NF2 and pachyonychia congenita: These results are in line with data from patient samples from the ICGC, in which low Merlin/high FAK status co-correlate with poor patient survival in PC and may represent a subset of patients who could substantially benefit from FAKi priming with chemotherapy in a stratified manner.